Visa (V)
(Delayed Data from NYSE)
$284.77 USD
-0.47 (-0.16%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $284.25 -0.52 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$284.77 USD
-0.47 (-0.16%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $284.25 -0.52 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Zacks News
Wall Street Analysts Think Visa (V) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Visa (V) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Visa (V) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Visa (V) closed the most recent trading day at $290.37, moving +1.05% from the previous trading session.
Visa Inc. (V) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Visa (V) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Affirm Stock Soars 72% in a Year: Is It the Right Time to Invest?
by Debasmita Chatterjee
Despite rising costs and stiff competition, AFRM's AI-driven platform is revolutionizing payments in the BNPL market. An extensive merchant network remains an added strength.
Visa and 1Link Team Up to Expand Digital Payments in Pakistan
by Zacks Equity Research
The scope for V in Pakistan is substantial, given the country's large unbanked population and growing need for digital payment solutions.
The Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian
by Zacks Equity Research
Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian are included in this Analyst Blog.
Visa (V) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Visa (V) settling at $285.34, representing a -0.09% change from its previous close.
Top Stock Reports for Visa, AbbVie & Anheuser-Busch
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Servotronics, Inc. (SVT) and United-Guardian, Inc. (UG).
Mastercard Up 11.6% YTD: Is It Worth Buying the Stock Right Now?
by Zubia Masood
MA benefits from rising payment volume and value-added services and solutions growth, coupled with the ongoing secular shift to digital payments.
Visa Stock Up Nearly 9% in a Month: Is Now the Right Time to Invest?
by Kaibalya Pravo Dey
V's investments in advancing cybersecurity and fraud prevention enhance its appeal to both consumers and merchants.
Bull of the Day: PayPal (PYPL)
by Andrew Rocco
Venmo growth, strong partnerships, and a cheap valuation are bullish catalysts for PayPal shares over the next 6-12 months.
Why the Market Dipped But Visa (V) Gained Today
by Zacks Equity Research
The latest trading day saw Visa (V) settling at $278.54, representing a +0.79% change from its previous close.
Visa Inc. (V) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Visa (V) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
MasterCard (MA) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MasterCard (MA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmEx Stock Rallies 37.2% YTD: Time to Buy, Sell or Hold?
by Zubia Masood
AXP continues to benefit from new card acquisitions, fee growth and improved net interest income.
Affirm Holdings Q4 Loss Narrows Y/Y, GMV Outlook Raised
by Zacks Equity Research
AFRM expects GMV of more than $33.5 billion in fiscal 2025.
3 Fintech Stocks to Buy: AFRM, UPST, PYPL
by Andrew Rocco
New economy fintech and payment stocks exhibit strong growth and bullish prospects. Affirm's bullish earnings report last night should bolster this market segment further into 2025.
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
by Zacks Equity Research
Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical are included in this Analyst Blog.
Visa (V) Stock Moves -0.57%: What You Should Know
by Zacks Equity Research
Visa (V) closed at $269.19 in the latest trading session, marking a -0.57% move from the prior day.
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The Walt Disney Company (DIS), as well as two micro-cap stocks FitLife Brands, Inc. (FTLF) and Utah Medical Products, Inc. (UTMD).
Should You Invest in the Financial Select Sector SPDR ETF (XLF)?
by Zacks Equity Research
Sector ETF report for XLF
Visa to Enhance Digital Payments With New Advisory Service
by Zacks Equity Research
Continuous addition of such new value-added services helps V to stay in the leading position in the payments landscape.
Should You Invest in the Fidelity MSCI Financials Index ETF (FNCL)?
by Zacks Equity Research
Sector ETF report for FNCL
Top Stock Reports for Texas Instruments, Union Pacific & Vertex Pharmaceuticals
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), Union Pacific Corporation (UNP) and Vertex Pharmaceuticals Incorporated (VRTX), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Gencor Industries, Inc. (GENC).
Why Is Visa (V) Up 5.5% Since Last Earnings Report?
by Zacks Equity Research
Visa (V) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.